Brief: Fusion Pharmaceuticals Announces First Quarter 2022 Financial Results And Clinical Program Updates

Fusion Pharmaceuticals

10/05/2022 12:08

May 10 (Reuters) - Fusion Pharmaceuticals Inc  FUSN.O :
    * FUSION PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2022
FINANCIAL
RESULTS AND CLINICAL PROGRAM UPDATES
    * PHASE 1 DATA FOR FPI-1434 ANTICIPATED TO BE REPORTED IN
SECOND
HALF OF 2022
    * FUSION PHARMA - ADVANCING ADDITIONAL PROGRAMS WITH
INVESTIGATIONAL NEW DRUG APPLICATION FILING FOR FPI-2059
ANTICIPATED IN Q2 OF 2022
    * EXPECT FIRST NOVEL TAT UNDER COLLABORATION AGREEMENT WITH
ASTRAZENECA IN IND-ENABLING STUDIES
    * QTRLY LOSS PER SHARE $0.46
    * Q1 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn5zSZbWa 
Further company coverage:  FUSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))